Terms: = Gastric cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Treatment
27 results:
1. Clinicopathological and prognostic features of Borrmann type IV gastric cancer versus other Borrmann types: A unique role of signet ring cell carcinoma.
Liang C; Liang Y; Ou B; Yuan L; Yuan S
Saudi J Gastroenterol; 2023; 29(4):240-250. PubMed ID: 37470667
[TBL] [Abstract] [Full Text] [Related]
2. Feasibility of endoscopic resection and impact of endoscopic ultrasound-based surveillance on colorectal subepithelial tumors.
Park EY; Baek DH; Hong SM; Lee BE; Lee MW; Kim GH; Song GA
Surg Endosc; 2023 Sep; 37(9):6867-6876. PubMed ID: 37311889
[TBL] [Abstract] [Full Text] [Related]
3. Intraductal Papillary Mucinous Neoplasm Arising from Heterotopic Pancreas in Stomach: A Case Report and Review of Literature.
Pang Y; Liu Y; Liu Q; Hou G
Int J Surg Pathol; 2023 Aug; 31(5):708-713. PubMed ID: 35946106
[TBL] [Abstract] [Full Text] [Related]
4. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
5. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
[No Abstract] [Full Text] [Related]
6. [Analysis of clinicopathologic characteristics of gastric cancer patients undergoing gastrectomy based on a single-center gastric cancer database with above 10 000 cases].
Liang WQ; Xi HQ; Qiao S; Cui JX; Zhang KC; Gao YH; Song YN; Zhang L; Luo H; Wei B; Xue WG; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1051-1058. PubMed ID: 33212553
[No Abstract] [Full Text] [Related]
7. Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced gastric cancer: The KLASS-02-RCT Randomized Clinical Trial.
Hyung WJ; Yang HK; Park YK; Lee HJ; An JY; Kim W; Kim HI; Kim HH; Ryu SW; Hur H; Kim MC; Kong SH; Cho GS; Kim JJ; Park DJ; Ryu KW; Kim YW; Kim JW; Lee JH; Han SU;
J Clin Oncol; 2020 Oct; 38(28):3304-3313. PubMed ID: 32816629
[TBL] [Abstract] [Full Text] [Related]
8. miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer.
Wu S; Xie J; Shi H; Wang ZW
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32065219
[TBL] [Abstract] [Full Text] [Related]
9. Clinical usefulness of ramucirumab plus paclitaxel for unresectable and recurrent gastric cancer.
Hayase S; Yamada L; Ujiie D; Nirei A; Tada T; Hanayama H; Monma T; Saze Z; Ohki S; Kono K
Fukushima J Med Sci; 2019; 65(1):6-12. PubMed ID: 30996218
[TBL] [Abstract] [Full Text] [Related]
10. Stage-matched survival differences by ethnicity among gastric cancer patients of Asian ancestry treated in the United States.
Rhome RM; Ru M; Moshier E; Mazumdar M; Buckstein MH
J Surg Oncol; 2019 May; 119(6):737-748. PubMed ID: 30694524
[TBL] [Abstract] [Full Text] [Related]
11. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With gastric cancer.
Li X; Pasche B; Zhang W; Chen K
JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
[TBL] [Abstract] [Full Text] [Related]
12. Early tumor shrinkage and depth of response in patients with advanced gastric cancer: a retrospective analysis of a randomized phase III study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin.
Nishina T; Azuma M; Nishikawa K; Gotoh M; Bando H; Sugimoto N; Amagai K; Chin K; Niwa Y; Tsuji A; Imamura H; Tsuda M; Yasui H; Fujii H; Yamaguchi K; Yasui H; Hironaka S; Shimada K; Miwa H; Mitome T; Kageyama H; Hyodo I
Gastric Cancer; 2019 Jan; 22(1):138-146. PubMed ID: 29948386
[TBL] [Abstract] [Full Text] [Related]
13. Maintenance proton pump inhibition therapy and risk of oesophageal cancer.
Brusselaers N; Engstrand L; Lagergren J
Cancer Epidemiol; 2018 Apr; 53():172-177. PubMed ID: 29477057
[TBL] [Abstract] [Full Text] [Related]
14. Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal cancer.
de Heer EC; Hulshoff JB; Klerk D; Burgerhof JGM; de Groot DJA; Plukker JTM; Hospers GAP
Ann Surg Oncol; 2017 Jul; 24(7):1811-1820. PubMed ID: 28188501
[TBL] [Abstract] [Full Text] [Related]
15. High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication: A pilot empirical second-line rescue therapy.
Mahmoudi L; Farshad S; Seddigh M; Mahmoudi P; Ejtehadi F; Niknam R
Medicine (Baltimore); 2016 Oct; 95(42):e4410. PubMed ID: 27759625
[TBL] [Abstract] [Full Text] [Related]
16. Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery.
Goossens N; Hoshida Y; Song WM; Jung M; Morel P; Nakagawa S; Zhang B; Frossard JL; Spahr L; Friedman SL; Negro F; Rubbia-Brandt L; Giostra E
Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1619-1628. PubMed ID: 26492845
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Significance of Molecular Analysis of Peritoneal Fluid for Patients with gastric cancer: A Meta-Analysis.
Deng K; Zhu H; Chen M; Wu J; Hu R; Tang C
PLoS One; 2016; 11(3):e0151608. PubMed ID: 26986965
[TBL] [Abstract] [Full Text] [Related]
18. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer.
Pang W; Lou N; Jin C; Hu C; Arvine C; Zhu G; Shen X
Eur J Gastroenterol Hepatol; 2016 May; 28(5):493-502. PubMed ID: 26854795
[TBL] [Abstract] [Full Text] [Related]
19. Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
Zhang Y; Pan KF; Zhang L; Ma JL; Zhou T; Li JY; Shen L; You WC
Carcinogenesis; 2015 Dec; 36(12):1572-9. PubMed ID: 26449252
[TBL] [Abstract] [Full Text] [Related]
20. A modified DCF regimen as primary treatment for patients with metastatic gastric cancer.
Koca D; Dogan E; Yardim H; Duzen O; Karaca S
J BUON; 2013; 18(2):377-84. PubMed ID: 23818349
[TBL] [Abstract] [Full Text] [Related]
[Next]
